D. TanphaichitraS. SrimuangP. ChiaprasittigulP. MendayO. E. ChristensenMahidol UniversityLeo Laboratories LimitedHolbaek Sygehus2018-10-122018-10-121984-11-01Infection. Vol.12, No.6 (1984), 381-38314390973030081262-s2.0-0021683977https://repository.li.mahidol.ac.th/handle/20.500.14594/30660Thirty-nine patients with acute enteric fever received the fixed-dose oral combination of pivmecillinam/pivampicillin. Thirty-seven (95%) subjects responded satisfactorily. No relapses or persistent faecal excretion of salmonellae were seen in the 29 patients followed up for 2 to 19 weeks. The treatment was well tolerated, no side-effects being recorded. In vitro studies revealed a synergistic interaction between mecillinam and ampicillin against isolates of Salmonella paratyphi A. © 1984 MMV Medizin Verlag GmbH München.Mahidol UniversityMedicineArticleSCOPUS10.1007/BF01645219